Medical treatment in addition to a primary treatment to maximise effectiveness.
1Forty one patients underwent craniospinal irradiation and 27 patients received adjuvant chemotherapy.
2Multivariate analysis retained previous adjuvant chemotherapy as a negative survival prognostic factor.
3The median duration of adjuvant chemotherapy was 18 weeks in both groups.
4Additionally, the benefit of adjuvant chemotherapy post-liver resection remained in sensitivity analysis.
5Methodology: 30 patients received adjuvant chemotherapy following surgical resection for pancreatic cancer.
6The patient received adjuvant chemotherapy according to Ewing's sarcoma chemotherapy protocol.
7Neither adjuvant chemotherapy nor radiotherapy had been given after the operation.
8Further evidence is needed to characterize the role of adjuvant chemotherapy.
9Patients were randomized to receive either adjuvant chemotherapy or observation after surgical resection.
10Seven patients were treated with adjuvant chemotherapy following surgery with a cisplatin-containing combination.
11Patients with lymph node-positive metastases seem to benefit the most from adjuvant chemotherapy.
12One month after surgery the patient began adjuvant chemotherapy with gemcitabine.
13Surgical resection was the treatment of choice, occasionally with adjuvant chemotherapy.
14Based on recent evidence, platinum-based adjuvant chemotherapy after complete resection should be considered.
15Additionally, several metanalysis failed to demonstrate a significant survival advantage with adjuvant chemotherapy.
16Several clinical trials of adjuvant chemotherapy are now underway in Japan.
Translations for adjuvant chemotherapy